FDA Orphan Exploitation? Are Pharma’s Approaches to Orphan Oncology Drug Approval Fuelling a Push for Reform By the FDA?
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1738
https://www.valueinhealthjournal.com/article/S1098-3015(18)32060-6/fulltext
Title :
FDA Orphan Exploitation? Are Pharma’s Approaches to Orphan Oncology Drug Approval Fuelling a Push for Reform By the FDA?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32060-6&doi=10.1016/j.jval.2018.04.1738
First page :
Section Title :
Open access? :
No
Section Order :
976